Stock·NYSE·Consumer Cyclical
Royal Caribbean Cruises Ltd. (RCL)
- Market cap
- $87.51B
- P/E
- 19.36
- Dividend yield
- 1.68%
- Street target
- $359.00median of 29 analysts
- 52-week range
- $222.22 $356.39
RCL stock forecast today
Where RCL stands today, and what CleaRank Financial AI makes of it.
RCL at a glance
Royal Caribbean Cruises Ltd. (RCL): Buy, 76/100 on CleaRank's AI score.
- Trend Mixed: the price is above both its 50- and 200-day moving averages, though the 50-day is still below the 200-day ($275.13 and $287.57).
- Earnings RCL beat estimates in 7 of its last 8 quarters, yet fell in the first session after 2 of those beats.
- Insiders Insiders sold $643.0M and made no open-market purchases over the last 18 months.
- Valuation P/E of 19.4 against 20.8 for the Consumer Cyclical sector: broadly in line with peers (-7%).
Figures as of November 6, 2026.
CleaRank Financial AI
Royal Caribbean Cruises Ltd. (RCL) carries a CleaRank rating of Buy and a model score of 76/100.
Trend contributes most to that score: the price sits 13.77% above its 200-day average and 18.91% above its 50-day average. Valuation pulls hardest against it, with the P/S of 4.57 running 140.5% above the sector median. The 50-day average is $275.13 and the 200-day is $287.57. Across the past year, the price climbed 29.02%.
Only on CleaRank
Figures we compute ourselves from RCL's own price, earnings and insider-filing history. Tap one to see it in context.
RCL stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $327.16 is 18.9% above the 50-day simple moving average of $275.13.Price above its 200-day average ›
The price is 13.8% above the 200-day simple moving average of $287.57.50-day average below the 200-day ›
The 50-day average ($275.13) is 4.3% below the 200-day average ($287.57), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 78% of its 52-week range, between $222.22 and $356.39.
RCL share price
Pick a period: each tab shows how far RCL has moved over it, to the last close.
Today's trading
Where RCL sits inside today's range and its 52-week range.
RCL fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 19.36 is 6.9% below the Consumer Cyclical median of 20.8.P/S above the sector median ›
The price-to-sales ratio of 4.57 is 140.7% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $4.6B on revenue of $19.1B, a net margin of 23.8%.Beat estimates in most recent reports ›
RCL beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.68%, or $5.50 a share a year.
Key statistics
The headline figures for RCL.
As of November 6, 2026, RCL trades at $327.16, with a market value of $87.51B, a P/E ratio of 19.36 and a dividend yield of 1.68%.
What the numbers say
CleaRank Financial AI's reading of RCL's valuation, growth and risks.
Trading at a trailing P/E of 19.36, RCL sits 6.9% below the Consumer Cyclical median of 20.8, and the peer comparison on this page rates that multiple as broadly in line with peers. On sales, the P/S of 4.57 stands 140.5% above the sector median of 1.9. To put the size in context, the company has a market value of $87.5B and trailing earnings of $16.90 per share.
Its net margin is 23.79% and its operating margin is 33.61%, which shows how much of each sales dollar it keeps. Return on equity stands at 41.29%, above the sector median of 12.4%. Debt-to-equity is 1.94, and the trailing dividend yield is 1.68%, or $5.50 a share a year.
RCL's most recent quarterly report, dated October 27, 2026, showed EPS of $6.57 against an estimate of $6.38, a beat of 2.98%. In the first session after the report, the share price moved up 5.46%.
RCL beat the EPS estimate in 7 of its last 8 reports, though the stock still fell in the first session after 2 of those 7 beats. The January 29, 2026 report stands out among the few before the latest: in line with the estimate, after which the stock rose 18.65%. The consensus EPS estimate stands at $17.93 for this fiscal year and $20.48 for next, growth of 14.7% for the current year.
The 30-day standard deviation of RCL's daily returns is 2.80%; measured against the S&P 500, its beta is 1.86. Over the last 18 months, insider sales totalled $643.0M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
RCL against the Consumer Cyclical sector
How RCL compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-7% against the sector median P/E).
Return vs SPY: Since May 28, 2025, RCL has gained 30.5% against a gain of 25.1% for SPY.
Performance against SPY
RCL and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much RCL sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); RCL reported again on October 27, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 8.8% in FY2025 to $17.9B, from $16.5B a year earlier.
Profit margin: The net margin was 23.9% in FY2025, up from 17.6% the year before.
Profitable: RCL earned $4.3B in FY2025.
Earnings reality check
Did RCL beat what analysts expected, and how did the stock react?
Earnings record: RCL beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 27, 2026before open | $6.38 | $6.57 | +2.98% | +5.46% | +14.42% |
| Jul 28, 2026before open | $3.98 | $4.21 | +5.78% | +5.72% | +6.22% |
| Apr 30, 2026before open | $3.20 | $3.60 | +12.50% | +3.84% | +13.02% |
| Jan 29, 2026before open | $2.80 | $2.80 | +0.00% | +18.65% | +12.71% |
| Oct 28, 2025before open | $5.68 | $5.75 | +1.23% | -8.53% | -13.26% |
| Jul 29, 2025before open | $4.08 | $4.38 | +7.35% | -5.01% | -10.31% |
| Apr 29, 2025before open | $2.53 | $2.71 | +7.11% | +0.12% | +5.75% |
| Jan 28, 2025before open | $1.50 | $1.63 | +8.67% | +12.00% | +10.15% |
As of November 6, 2026, RCL has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on October 27, 2026, came in 2.98% above the estimate and the stock moved +5.46% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
RCL AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 66.7, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 66.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of RCL
The score, the reasoning behind it, and what could move the price next.
RCL is in an uptrend: at $327.16, it trades 18.91% above its 50-day average of $275.13 and 13.77% above its 200-day average of $287.57. At 78% of its 52-week range, the price is 8.20% below the 52-week high of $356.39. The 50-day average runs 4.33% below the 200-day average, so the longer-run structure has not turned up yet, even with the price back above the shorter average.
On momentum, the 14-day RSI reads 66.7, in the bullish zone, below the overbought line, with the MACD line positive. The recent returns all show a gain, with the price up 2.24% over the past three months, 18.86% over the past six months and 29.02% over the past year. The price rose 1.37% in the last session on volume 40.4% below its average.
Earnings beat ›
The October 27, 2026 report beat the EPS estimate by 2.98%, and the share price rose 5.46% in the first session after it.
Source: Earnings report, October 27, 2026Analyst upgrade ›
Freedom Broker upgraded it to Buy from Hold on October 28, 2026.
Source: Analyst action, Freedom Broker, October 28, 2026Rating reaffirmed ›
Citigroup kept its Buy rating on October 29, 2026.
Source: Analyst action, Citigroup, October 29, 2026
- Keep an eye on the two nearest levels: the 52-week high at $356.39 above the price, and the 20-day EMA at $300.88 below it.
- A 14-day RSI of 66.7 places RCL in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- The share price rose 5.46% in the first session after the October 27, 2026 report. RCL has beaten estimates in 7 of the last 8 reports.
RCL is in an uptrend, trading above its 50-day and 200-day moving averages ($275.13 and $287.57). A drop through the 200-day would be the first sign of weakness. The closest support beneath the price is the 20-day EMA, at $300.88.
The next level overhead for RCL is the 52-week high at $356.39. The RSI reading sits in the bullish band, which supports the current direction while remaining close to the overbought threshold.
Technical indicators
Momentum and trend for RCL, from its daily closes.
As of November 6, 2026, with RCL at $327.16, its 14-day RSI is 66.7 (showing bullish momentum without being overbought), its 50-day simple moving average is $275.13 and its 200-day is $287.57.
Calculated by CleaRank on daily closes as of November 6, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What RCL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 6, 2026, RCL's 1-year correlation of daily returns is +0.57 with S&P 500 (SPY), +0.49 with Nasdaq 100 (QQQ), +0.04 with Bitcoin (BTC) and +0.06 with gold (XAU).
RCL price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
24 of 29 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $359.00 is 9.7% above the price.Larger share of buy ratings than three months ago ›
24 of 29 rate it a buy now, against 19 of 28 three months ago.
RCL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 29, 2026 | Citigroup | Maintains | Buy |
| Oct 28, 2026 | Freedom Broker | Upgrade | Buy |
| Oct 28, 2026 | Jefferies | Maintains | Buy |
| Oct 28, 2026 | Barclays | Maintains | Overweight |
| Oct 28, 2026 | Wells Fargo | Maintains | Overweight |
| Oct 28, 2026 | Susquehanna | Maintains | Positive |
As of November 6, 2026, 29 Wall Street analysts cover RCL: 24 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $270.00 to $425.00. The median RCL price target is $359.00, 9.7% above the price of $327.16.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
RCL risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much RCL tends to move, against the market and on its own.
RCL price history and drawdowns
RCL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Typical daily move of 2% or more ›
A typical daily move is 2.80% (the standard deviation of the last 30 daily returns).Recovered from its worst fall ›
The worst fall was 78.9%, from January 2020 to March 2020, regained by March 2024.Most 1-year holds ended higher ›
61% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since December 2016 ›
$10,000 invested in December 2016 is now worth $46,305, against $39,188 in the S&P 500 (SPY).
RCL Drawdowns & Recovery
As of November 6, 2026, RCL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -78.9% (January 2020 to March 2020); it regained that peak by March 2024, 48 months after the low, and 61% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RCL in December 2016 is worth now, against the same amount in the S&P 500.
Against the market: RCL beat the S&P 500 over this period: $46,305 against $39,188.
A $10,000 investment in RCL in December 2016 would be worth about $46,305 today with dividends reinvested, compared with about $39,188 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RCL, and which have not.
Strongest month, November: an average of +10.68%, up in 7 of 9 years.
Weakest month, March: an average of -10.34%, up in 3 of 10 years.
This month, November: has averaged +10.68%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Across 10 calendar years of history, RCL's strongest calendar month has been November (average +10.68%, up in 7 of 9 years) and its weakest March (average -10.34%, up in 3 of 10 years).
Average return for each calendar month across 10 calendar years of history, from weekly closing prices with dividends included.
RCL stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RCL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in RCL today could grow to about $14,272 by 2030 in the base case, with a 90th-percentile outcome near $51,412 and a 10th-percentile outcome around $3,962. The simulation models price only; at today's 1.68% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
RCL Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $467 for RCL by 2030 in the base case, from $327 today (1.4x over 4 years). The 10th-percentile path ends near $130. These are outcomes of a Monte Carlo simulation run on RCL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $188 | $358 | $679 | |
| 2028 | $158 | $391 | $967 | |
| 2029 | $141 | $427 | $1,296 | |
| 2030 | $130 | $467 | $1,682 |
Method: a lognormal simulation of RCL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. RCL is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
RCL insider trading
What the people running the company have bought and sold.
RCL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought RCL shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of November 6, 2026, RCL insiders reported 18 open-market sales worth $643.0M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Michael W Bayley
Officer
|
Sell | 12.8K | $4.0M |
| May 28, 2026 | John F Brock
Director
|
Grant | 831 | - |
| May 28, 2026 | Richard David Fain
Director
|
Grant | 831 | - |
| May 28, 2026 | Stephen R. Howe Jr
Director
|
Grant | 831 | - |
| May 28, 2026 | Michael O Leavitt
Director
|
Grant | 831 | - |
| May 28, 2026 | Amy C. McPherson
Director
|
Grant | 831 | - |
| May 28, 2026 | Maritza Gomez Montiel
Director
|
Grant | 831 | - |
| May 28, 2026 | Eyal Ofer
Director
|
Grant | 831 | - |
| May 28, 2026 | Vagn O Sorensen
Director
|
Grant | 831 | - |
| May 28, 2026 | Donald Thompson
Director
|
Grant | 831 | - |
| May 28, 2026 | Christopher J. Wiernicki
Director
|
Grant | 571 | - |
| May 28, 2026 | Christopher J. Wiernicki
Director
|
Grant | 831 | - |
| May 28, 2026 | Arne Alexander Wilhelmsen
Director
|
Grant | 831 | - |
| Feb 27, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 771.6K | $243.6M |
| Feb 27, 2026 | Christopher J. Wiernicki
Director
|
Grant | 444 | - |
| Feb 24, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 473.5K | $149.4M |
| Feb 19, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 206.4K | $65.4M |
| Feb 17, 2026 | Arne Alexander Wilhelmsen
Director
|
Sell | 280.0K | $91.2M |
| Feb 17, 2026 | Laura H Bethge
Officer
|
Sell | 7.9K | $2.6M |
| Feb 17, 2026 | Maritza Gomez Montiel
Director
|
Sell | 1.4K | $453.1K |
| Feb 13, 2026 | Jason T Liberty
Chief Executive Officer
|
Sell | 90.9K | $29.7M |
| Feb 13, 2026 | Michael W Bayley
Officer
|
Sell | 80.0K | $26.1M |
| Feb 13, 2026 | Naftali Holtz
Chief Financial Officer
|
Sell | 51.1K | $16.7M |
| Feb 13, 2026 | Henry L Pujol
Officer
|
Sell | 4.4K | $1.5M |
| Feb 13, 2026 | Naftali Holtz
Chief Financial Officer
|
Grant | 750 | - |
| Feb 10, 2026 | Michael W Bayley
Officer
|
Grant | 173.7K | - |
| Feb 10, 2026 | Laura H Bethge
Officer
|
Grant | 35.0K | - |
| Feb 10, 2026 | Naftali Holtz
Chief Financial Officer
|
Grant | 66.0K | - |
| Feb 10, 2026 | Harri U Kulovaara
Officer
|
Grant | 45.1K | - |
| Feb 10, 2026 | Robert Alexander Lake
Officer
|
Grant | 30.5K | - |
| Feb 10, 2026 | Jason T Liberty
Chief Executive Officer
|
Grant | 296.3K | - |
| Feb 10, 2026 | Henry L Pujol
Officer
|
Grant | 11.4K | - |
| Dec 23, 2025 | Richard David Fain
Director
|
Grant | 17.6K | - |
| Nov 3, 2025 | Maritza Gomez Montiel
Director
|
Sell | 1.1K | $309.9K |
| Oct 2, 2025 | John F Brock
Director
|
Grant | 3.2K | - |
| Aug 19, 2025 | Vagn O Sorensen
Director
|
Sell | 10.3K | $3.4M |
| Aug 6, 2025 | Richard David Fain
Director
|
Sell | 16.0K | $5.0M |
| Jul 30, 2025 | Henry L Pujol
Officer
|
Sell | 5.2K | $1.7M |
| Jun 27, 2025 | Robert Alexander Lake
Officer
|
Sell | 2.9K | $860.3K |
| Jun 6, 2025 | Robert Alexander Lake
Officer
|
Sell | 2.5K | $687.5K |
| May 28, 2025 | John F Brock
Director
|
Grant | 870 | - |
| May 28, 2025 | Richard David Fain
Director
|
Grant | 870 | - |
| May 28, 2025 | Stephen R. Howe Jr
Director
|
Grant | 870 | - |
| May 28, 2025 | Michael O Leavitt
Director
|
Grant | 870 | - |
| May 28, 2025 | Amy C. McPherson
Director
|
Grant | 870 | - |
| May 28, 2025 | Maritza Gomez Montiel
Director
|
Grant | 870 | - |
| May 28, 2025 | Ann S Moore
Director
|
Grant | 870 | - |
| May 28, 2025 | Eyal Ofer
Director
|
Grant | 870 | - |
| May 28, 2025 | Vagn O Sorensen
Director
|
Grant | 870 | - |
| May 28, 2025 | Donald Thompson
Director
|
Grant | 870 | - |
| May 28, 2025 | Arne Alexander Wilhelmsen
Director
|
Grant | 870 | - |
| May 28, 2025 | Rebecca Yeung
Director
|
Grant | 870 | - |
| May 12, 2025 | Maritza Gomez Montiel
Director
|
Sell | 1.5K | $363.7K |
Source: TwelveData, from SEC Form 4 filings
RCL stock forecast: questions people ask
Answered from the figures on this page, as of November 6, 2026.